Stay updated with breaking news from Stephen mayo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its price target lifted by Mizuho from $145.00 to $179.00 in a research report sent to investors on Friday morning, Benzinga reports. Mizuho currently has a buy rating on the biotechnology company’s stock. SRPT has been the topic of several other research reports. UBS Group raised their price […] ....
McEnroe Bros Raise $300,000 at the JMTP Comedy-Night Fund Raiser - 10sBalls.com • TennisBalls.com 10sballs.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 10sballs.com Daily Mail and Mail on Sunday newspapers.
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) shot up 5.9% during mid-day trading on Wednesday . The stock traded as high as $124.37 and last traded at $124.01. 550,813 shares traded hands during trading, a decline of 43% from the average session volume of 972,684 shares. The stock had previously closed at […] ....
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Stock analysts at William Blair reduced their FY2024 EPS estimates for Sarepta Therapeutics in a research report issued on Wednesday, April 17th. William Blair analyst T. Lugo now forecasts that the biotechnology company will post earnings per share of $6.66 for the year, down from their previous […] ....
Peregrine Capital Management LLC Trims Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.